Skip to main content
All lobbying filings

ELEKTA, INC.

Lobbying for ELEKTA, INC.

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jun 29, 2026
Expenses
$70,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 7

HHS, Labor and Education Appropriations Energy Appropriations

Gamma Knife/Cobalt-60 Nuclear Material for Medical Use Radioactive Material for Medical Use

Radiation Oncology/ Radiation Therapy Cancer Care General Oncology issues Healthcare reimbursement

Radiation Oncology Cancer Care

ROCR legislation H.R. 1031 and S. 2021 Medicare access Medicare reimbursement General Medicare issues Medicaid access Medicaid reimbursement General Medicaid issues

General Tariff issues USMCA US-EU trade agreement US-UK trade agreement

General Trade issues USMCA US-EU trade deal US-UK trade deal

 Bills named in this filing 2
  • H.R. 1031
    Insular Areas College Access Act
  • S. 2021
    Close the Round-Tripping Loophole Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem